Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis.

scientific article published in November 1998

Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00000658-199811000-00006
P932PMC publication ID1191572
P698PubMed publication ID9833805
P5875ResearchGate publication ID13452648

P2093author name stringH J Buhr
M Kirchengast
J Faulhaber
H G Hotz
T Foitzik
P2860cites workPathogenesis and Prevention of Early Pancreatic Infection in Experimental Acute Necrotizing PancreatitisQ71970381
Isovolemic Hemodilution with Dextran 60 as Treatment of Pancreatic Ischemia in Acute Pancreatitis Clinical Practicability of an Experimental ConceptQ72076066
Multicentre audit of death from acute pancreatitisQ72092003
Role of Pancreatic Blood Flow and Vasoactive Substances in the Development of Canine Acute PancreatitisQ72103613
Measurement of blood flow in pancreatic exchange capillaries with FITC-labeled erythrocytesQ72226811
Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the ratQ72693612
Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertensionQ73086588
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorQ28580331
A novel potent vasoconstrictor peptide produced by vascular endothelial cellsQ29620540
Effects of endothelin on microcirculation of the pancreasQ33231456
A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem.Q34364007
Endothelins: polyfunctional cytokines.Q40525347
The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspectiveQ40983711
Ingredients of organ dysfunction or failureQ41004750
Cloning and expression of a cDNA encoding an endothelin receptorQ41710266
Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitisQ42074855
Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonistsQ42555888
Hyperoncotic ultrahigh molecular weight dextran solutions reduce trypsinogen activation, prevent acinar necrosis, and lower mortality in rodent pancreatitisQ44035193
A better model of acute pancreatitis for evaluating therapyQ67731112
Continuous complete collection of uncontaminated urine in conscious rodentsQ68261875
Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP)Q68451784
Antibiotic treatment improves survival in experimental acute necrotizing pancreatitisQ70824669
Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden deathQ70966642
Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitisQ71147580
Isovolemic hemodilution with dextran prevents contrast medium induced impairment of pancreatic microcirculation in necrotizing pancreatitis of the ratQ71667716
Effect of endothelin-1 on the development of hemorrhagic pancreatitis in ratsQ71695753
Protective effects of endothelin-1 on acute pancreatitis in ratsQ71697016
Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitisQ71907209
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)670-675
P577publication date1998-11-01
P1433published inAnnals of SurgeryQ4767866
P1476titleEndothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis.
P478volume228

Reverse relations

cites work (P2860)
Q57570913An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis
Q74049545Differential effects of ET-1, ET-2, and ET-3 on pancreatic microcirculation, tissue integrity, and inflammation
Q28580085ETA and ETB receptor function in pancreatitis-associated microcirculatory failure, inflammation, and parenchymal injury
Q35359195Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis
Q41865519Effect of endothelin-1 receptor antagonists on histological and ultrastructural changes in the pancreas and trypsinogen activation in the early course of caerulein-induced acute pancreatitis in rats
Q30903551Endothelin A receptor blockade reduces hepatic ischemia/reperfusion injury after warm ischemia in a pig model.
Q44883816Endothelin receptor antagonists are not beneficial in the therapy of acute experimental pancreatitis
Q31151502Endothelin(A) receptor blockade reduces ischemia/reperfusion injury in pig pancreas transplantation
Q52931543Endothelin-1 receptor antagonist (LU-135252) improves the microcirculation and course of TNBS colitis in rats.
Q45219605In vivo imaging of human pancreatic microcirculation and pancreatic tissue injury in clinical pancreas transplantation
Q44608586Influence of a selective endothelin(A) receptor antagonist on the quantitative mRNA expression and the immunohistochemistry of vasoactive mediators after pancreas transplantation
Q34668333Influencing factors of pancreatic microcirculatory impairment in acute panceatitis
Q52959143Persistent multiple organ microcirculatory disorders in severe acute pancreatitis: experimental findings and clinical implications.
Q77370371Protective effect of a selective endothelin a receptor antagonist (BSF 208075) on graft pancreatitis in pig pancreas transplantation
Q36066240Role of COX-2 in microcirculatory disturbance in experimental pancreatitis
Q52933500Selective COX-2 inhibition reduces leukocyte sticking and improves the microcirculation in TNBS colitis.
Q39488367The clinical course of acute pancreatitis and the inflammatory mediators that drive it.
Q44657272The effect of endothelin-1 receptor antagonists in acute experimental pancreatitis in the rats
Q73582179The endothelin antagonist bosentan does not improve survival in severe experimental pancreatitis in rats
Q36181321The endothelin receptor antagonist TAK-044 in the treatment of reperfusion injury in organ transplantation
Q33196197The endothelin-1 receptor antagonists ameliorate histology and ultrastructural alterations in the pancreas and decrease trypsinogen activation in severe taurocholate pancreatitis in rats
Q52538844Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist.
Q52536333Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade.